Related Experiment Videos
[Generics: essentially similar, bioequivalent but not identical].
D Even-Adin1, J A De Muylder, J Sternon
1Hôpital Erasme, U.L.B.
Revue Medicale De Bruxelles
|January 29, 2002
Summary
Generic drugs offer potential cost savings in pharmaceutical expenses. However, questions remain regarding their identity to original medications, particularly concerning excipients and bioavailability studies.
Area of Science:
- Pharmacoeconomics
- Pharmaceutical policy
Context:
- Generic drugs (GF) are gaining interest in Belgium due to reference repayment policies.
- European regulations govern the sale authorization of generic drugs.
Purpose:
- To investigate the identity and guarantees of generic drugs compared to original medications.
- To identify potential discordances in generic drug conformity.
Summary:
- Similarities based solely on active molecules, pharmaceutical forms, and bioavailability may not suffice.
- Key non-conformity elements include excipient nature, notice content, and bioavailability study validity.
- Despite concerns, the development of generic drugs is an unavoidable economic trend in the pharmaceutical market.
Impact:
- Highlights the need for rigorous evaluation of generic drugs beyond basic composition.
- Informs policymakers and healthcare providers about potential risks and economic benefits.
- Underscores the growing importance of generic drugs in managing pharmaceutical expenditure.